Vasoactive Peptides in Portal Pressure

NCT00163982 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2007-07-26

No results posted yet for this study

Summary

This study is looking at the detection of vasoactive peptides in portal hypertension.

Conditions

  • Portal Hypertension

Interventions

DRUG

Norfloxacin

Sponsors & Collaborators

  • Bayside Health

    lead OTHER_GOV

Principal Investigators

  • William W Kemp, MBBS, FRACP · The Alfred

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00163982 on ClinicalTrials.gov